Ontology highlight
ABSTRACT:
SUBMITTER: Zhou SJ
PROVIDER: S-EPMC5688922 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Zhou Shu-Juan SJ Wei Jia J Su Shu S Chen Fang-Jun FJ Qiu Yu-Dong YD Liu Bao-Rui BR
Journal of Cancer 20171017 18
Genetic engineering has resulted in more than 50 recombinant bispecific antibody formats over the past two decades. Bispecific scFv antibodies represent a successful and promising immunotherapy platform that retargets cytotoxic T cells to tumor cells, with one scFv directed to tumor-associated antigens and the other to T cells. Based on this antibody construct, strategies for both specific tumor targeting and T cell activation are reviewed here. Three distinct types of tumor antigens are conside ...[more]